INTRODUCTION
Drug eŠects and adverse reactions are not dependent only on a drug class. They also depend on patient characteristics such as genetic polymorphisms of drug-metabolizing enzyme, transporter and receptor. These factors are considered causal explanations for individual diŠerences of drug eŠects in recent years. Therefore, many studies at the genetic level for patient factors that in‰uence drug eŠects have been reported. 1 6) An early example of a report published as an alert is a report entitled Carbamazepine (marketed as Carbatrol, Equetro, Tegretol and generics), which was issued by the U.S. Food and Drug Administration (US FDA) on December 12, 2007 . 7) This alert discussed a genetic level study of clinical drug therapy as follows: the manufacturers of drugs containing the active ingredient carbamazepine (CBZ) have agreed to add to the drugs' labeling a recommendation that before starting therapy with the drugs, patients with Asian ancestry should get a genetic blood test that could identify an increased risk of developing a rare, but serious, skin reaction, as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). 8) The alert is based on the report of Hung et al. and Lonjou et al. Hung and colleagues reported that SJS/ TEN caused by CBZ is strongly associated with the Human Leukocyte Antigen (HLA)-B 1502 gene in Han Chinese. 1) Lonjou et al. reported that in a series of cases involving European patients with SJS/TEN associated with CBZ they found that patients who had Asian ancestry were over-represented, considering the small percentage of Asians in the general population. Of 12 patients, 4 were of Asian ancestry, and all 4 were positive for HLA-B 1502. 2) The relevance of this is now similarly recognized in SJS/TEN of Thais or Indians. 4, 5) In Japanese, how-ever, there are no reports about the association between HLA-B 1502 gene and CBZ-induced SJS/ TEN, though one report has indicated the association between allopurinol-induced SJS/TEN and HLA-B 5801. 6) Therefore, the relevance of the adverse eŠect by speciˆc drugs to a genetic background is strongly suggested.
Alternatively, reports indicate the close connection of Body Constitution (BC) with certain HLA-gene types. Chen et al. studied the association between HLA Class II polymorphism and the classiˆcation of BC based on theories of Physical Constitution of Traditional Chinese Medicine (TCM): Normality, Yin-deˆciency, Qi-deˆciency, Wetness-heat, Yangdeˆciency, Blood stasis and Phlegm-wetness. They reported that the allele frequencies of DPB1 0501 in the Yin-deˆciency group, DRB1 09012 in the Phlegmwetness group, and DQB1 3032 in Qi-deˆciency and Phlegm-wetness groups were signiˆcantly high from that of the corresponding alleles in the Normality constitution in 706 individuals in the Han ethnic group in South China. 8) This suggests that empirically classiˆed BC in traditional medicine such as TCM and Kampo medicine based on TCM and adapted in Japan may be associated with genetic predisposition.
Since the relationship between adverse drug reaction (ADR) and HLA polymorphism, and the relationship between BC and HLA polymorphism have been reported, a relationship between ADR and BC (ADR/BC-Relationship) is suggested. For this reason, we searched the literature for an ADR/BC relationship in the Igaku Chuo Zasshi database and PubMed with MeSH keywords: body constitution and adverse drug event. We found no relevant articles.
In previous report, we studied the frequency and type of BC information described in the ADR case reports. 9) Since BC information was minimal, it was suggested that the study of the ADR/BC relationship using reported data was di‹cult at present. Under these circumstances, in order to investigate the ADR/ BC relationship, we requested the participation of the SJS patient association. This association was the only association of patients with ADR that we couldˆnd listed on the Internet.
If we could discover the typical BC in SJS patients, which is diŠerent from healthy persons, such information might provide a key to elucidate the causal factor in developing SJS. Furthermore, the discovery might make the prevention of SJS possible.
Because there were no appropriate questionnaires to characterize ADR patients based on BC, we extracted a representative BC from the Kampo Medical Questionnaires used in the clinical setting.
To identify the characteristic BCs of SJS patients using Kampo Medical Questionnaires, 10 healthy persons were matched to 1 patient.
The age at which individuals developed ADR was diŠerent for each person, and the retrospective years of recall for BCs in the past from now to immediately before the onset was also diŠerent. Therefore, the matched items were age, sex and length of recall period.
METHODS

Preparation of Questionnaire
The Questionnaire used for the BC survey was developed based on the items composing the Sho-syndrome, used in Kampo Medicine. These items refer to the BC itself. Sho-syndrome is composed of several types of BC.
On the occasion of diagnosis and therapy of Kampo Medicine, Sho-syndrome is scaled in view of Yin-Yang (陰陽), and classiˆed into 6 diŠerent categories: Ki-kyo (気虚), ki-utsu (気鬱), Ki-gyaku (気 逆), Ketsu-kyo (血虚), O-ketu (血) and Sui-tai (水滞). Each BC item is given a score, 10) which is graded according to the contribution in determining Sho-syndrome.
Two specialists found high scored or typical 30 BCs in the 108 BCs that appeared in the Kampo Medicine textbook. 10) A few modiˆcations (addition of items and change in score value) were made with narrowing down the items. Each question in the Questionnaire has a three-option answer: (1) yes, (2) yes, but only occasionally and (3) no. The Questionnaire is shown in Table 1 . The classiˆcation and score value of each item are shown in Table 2 .
Survey Methods BC Survey of the SJS Patients In March 2008, Questionnaires were sent to the o‹ce of the SJS patient association (SJS Support Group, Yokosuka, Kanagawa, Japan) after explanation of the purpose of this study. The Questionnaires and prospectus were then sent to patients from the o‹ce of the SJS support group. Questionnaires completed by patients who agreed to participate in the study were returned to the o‹ce. We received the Questionnaires as 
Analysis Comparison of Prevalence of BC between SJS Group and Control Group
The frequency of respondents who answered``Yes'' and``Yes, but only occasionally'' for each item was compared between the SJS group and control group using a chi-square test.
Calculation of Boundary Sho-score Which Gives Maximum Value of Positive and Negative Likelihood Ratio Both a Yin-Yang (陰陽) score and 6 categories of Sho-syndrome were calculated for each person. A boundary score for each Sho-syndrome that gives maximum value of positive and negative likelihood ratio between the SJS group and the control group was calculated.
Decision Tree Analysis Decision tree analysis investigated and extracted the condition of SJS patients as compared to the control persons by comparing the presence or absence of a particular BC. Decision trees in which theˆrst node wasˆxed every 30 items were built. Items (BCs) that appeared at depth 3 of the decision tree were used to construct an extraction. The analyses were performed by JMP5.1.2 (SAS Institute Japan) for Windows.
The Josai University Ethics Committee determined that this study met its standards because the data was anonymous.
RESULTS
Questionnaires Used for Analysis
Sixty-nine Questionnaires were returned to us from the SJS support group o‹ce. Of the 69 Questionnaires, 12 were from SJS patients who developed SJS before 10 years of age. Because BC changes each year for those less than ten years old, recall is inaccurate. Therefore these patients were excluded from the analysis. Five Questionnaires were not completelyˆlled in. Of the 69 Questionnaires returned, 17 were excluded from the analysis, and the remaining 52 were analyzed. Patient data (sex, age, age at development and time period of recall) are shown in Table 3 .
The answers from 16 males and 36 females were analyzed. The mean age at the time of investigation was 45.7 years old (range: 18 to 76 years old). The mean age at the development of SJS was 30.6 years old (range: 10 to 59 years old). Since both the distribution and collection of the Questionnaires were performed by the SJS support group, the collection rate is unknown.
Comparison of Prevalence of BC between SJS Group and Control Group
In comparing the prevalence of BC between the 52 cases of SJS group and the 520 persons in the control group, the prevalence (response rate of``Yes, but only occasionally'' and``Yes'') of 3 items in the SJS group were signiˆcantly higher than in the control group (chi-square test, p＜0.05, Fig. 1 ); Q7 Does your throat ever feel The boundary Sho-score, which gives a maximum value of positive and negative likelihood ratio, is shown in Table 4 . When the boundary O ketu (血) score was set at 22, the highest positive likelihood ratio 10.00 was observed. The number of persons exceeding this boundary value was one in the SJS group and one in the control group. The diŠer-ences in the size (52 vs. 520) of the population which forms each group composed this result.
Next in order, positive likelihood ratios 8.00 and 7.5 were obtained by the boundary score of Ki-kyo (気虚): 30 and Ki-utsu (気鬱): 27, respectively. However sensitivities of both were low.
The highest negative likelihood ratio ranged from 0.90 to 1.36 in each Sho-syndrome. Therefore, the SJS group and the control group were not distinguished by the application of the Sho-score.
Decision Tree Analysis and Positive Likelihood Ratio
The analytical results using the decision tree are shown in Table 5 . In theˆrst depth node, the items that create higher concentrated group of the SJS patients were Q7, Q9 and Q18. The prevalence of these items in the SJS group was signiˆcantly higher than in the control group.
An example of the decision tree in which theˆrst depth node wasˆxed in Q7 (tree No. 7 in Table 5 ) is shown in Fig. 2 . Question 7 showed the highest positive likelihood ratio of 2.50 in 3 items. The number of SJS patients in theˆrst depth node was 11. The optimum second depth node determinant was Q18. Thè`Y es'' node had 7 patients and the rate of SJS was 50 percent. The positive likelihood ratio was 10.
Similarly, the optimum third depth node determinant was Q21 Do you easily become swollen and do you easily notice the sound of water in your stomach? Allˆve persons who answered``no'' to this item were SJS patients.
In order to investigate the typical BC of SJS patients, we focused on the tree including the node which tentatively indicated the positive likelihood ratio of 10. These trees and the extracted SJS patients are shown in Table 6 .
Since 
DISCUSSION
Reports indicate the relationship between the occurrence of ADR and HLA polymorphism and the relationship between BC and HLA polymorphism, but there are few reports about the relationship between ADR and BC. Therefore, in order to identify the relationship between ADR and BC, the BC of patients developed a representative ADR of SJS were surveyed using BC Questionnaires and analyzed. The results were that Sho-syndrome, which is the original indication of classiˆcation of BC in Kampo Medicine and was used as an information source of BC, could not be classiˆed into an SJS patient group and control group. However, the combination of patient BCs before SJS development could be classiˆed into an SJS patient group and control group with high value of positive likelihood ratio. The reason classiˆcation was di‹cult was that abstraction from 108 BCs to 30 BCs considered the convenience of the respondent. This abstraction might impede the correct classiˆcation of Sho-syndrome.
SJS is a serious adverse eŠect caused by diŠerent kinds of drugs. Once SJS occurs, it can be associated with poor prognoses, disorders of the eyes and respiratory tract, and other health problems and may remain even after skin symptoms have been reduced. 11) As the occurrence frequency of SJS is extremely low, such as 1 to 6 individuals per million/ year, SJS development is di‹cult to predict. Many 17) From the study results, patients extracted by trees No. 7 and No. 24 are considered at high risk of developing SJS. Also, having BCs described in Q7, Q9 and Q18 with prevalence signiˆcantly higher in SJS patients are indicative of SJS. This study proposed a novel method to predict SJS development based on BC. Further clinical practices to conˆrm the results of this study and to prevent ADR are our issues.
Next we discuss a causal connection between BC and pathogenesis before SJS development. SJS patients were extracted with a high value of positive likelihood ratio by combination of BCs selected as trees No. 7 and No. 24. However, only BCs selected as index variable by decision tree analysis are not always the speciˆc BCs of SJS patients. If complex BCs are simultaneously present in all patients, the same extraction is possible by either BC. For example, 10 SJS patients of 13 SJS patients who have BC of Q18 have BC of Q9. Thus BC of Q9 was not selected as an index variable, and the BC was masked. However, prevalence of BCs described Q7, Q9 and Q18 were signiˆcantly higher in SJS patients. Hence these are characteristic BCs of SJS patients. Among these, your throat makes you feel closed up (Q7) is reported to be an early symptom of SJS. 11) There is a possibility that SJS patient mistakenly answered Q7 as BC before developing SJS. Therefore, identiˆcation is di‹cult in that it is intrinsic in BC or early symptoms. However, it was reconˆrmed that Q7 is the alarming symptom or BC. We could notˆnd any reports about`y our throat making you feel closed up'' related to developing SJS. Alternatively,``Do you easily feel hot ‰ashes or burning checks, even though your hands or feet are cold'' (Q9) and``Do your lips or gums look dull red'' (Q18) possibly re‰ected a local ischemia or a disorder of peripheral blood ‰ow. The relationship between the occurrence of SJS and a disorder of skin blood ‰ow might require investigation.
The literature about the trigger for SJS/TEN examined the increase of trigger cells (CD94/NKG2C, HLA-DR ＋
D8
＋ ) in peripheral blood ‰ow. 18, 19) A disorder of peripheral blood circulation is possibly a risk factor for increased concentration of trigger cells.
Study Limitations
In this survey, an SJS patient group and a control group responded to questions about past BC recalling memories of 15.1 years earlier on average. Therefore it is necessary to consider the recall bias and reliability of memory. In general, the patient group remembered disease-associated past incidents clearly as compared with the control group. 20) Furthermore patients have a tendency to emphatically answer positively concerning exposure incidents which the patients think might have caused the disorder. In this study, the prevalence of BC in the SJS patient group (23.6％) was signiˆcant-ly higher than the control group (18.1％) (p＜0.01). In 23 of 30 items, the prevalence of the SJS patient group was higher than the control group. The questions in which prevalence was signiˆcantly diŠerent in SJS patients (Q7, Q9 and Q18) were higher prevalence in SJS patients, so recall bias might exist. However it is highly unlikely that SJS patients answered these questions consciously as cause of SJS development. For example, an SJS patient who thought that having lips or gums look dull red (Q18) was pathogenesis of disease was the exception rather than the norm. Therefore, it seemed that the in‰uence of recall bias was minimal. The fact that duration of recall was long might in‰uence the reliability of results. In this study, 10 healthy persons were matched to 1 patient, and compared under the same conditions of sex, age and recall period. In spite of these conditions we thought that there might be some inaccuracy based on uncertain memory.
